GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Gata2
|
ENSRNOG00000012347 | GATA binding protein 2 |
Gata1
|
ENSRNOG00000025534 | GATA binding protein 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Gata1 | rn6_v1_chrX_+_15378789_15378789 | 0.50 | 1.1e-21 | Click! |
Gata2 | rn6_v1_chr4_+_120133713_120133713 | 0.00 | 9.4e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_+_119225040 | 146.91 |
ENSRNOT00000012365
|
Bmp10
|
bone morphogenetic protein 10 |
chr4_+_57952982 | 135.57 |
ENSRNOT00000014465
|
Cpa1
|
carboxypeptidase A1 |
chr1_+_279798187 | 133.38 |
ENSRNOT00000024065
|
Pnlip
|
pancreatic lipase |
chr12_-_46889082 | 121.41 |
ENSRNOT00000001525
|
Pla2g1b
|
phospholipase A2 group IB |
chr14_+_26662965 | 120.68 |
ENSRNOT00000002621
|
Tecrl
|
trans-2,3-enoyl-CoA reductase-like |
chr5_-_155772040 | 110.46 |
ENSRNOT00000036788
|
Cela3b
|
chymotrypsin-like elastase family, member 3B |
chr4_+_70614524 | 98.01 |
ENSRNOT00000041100
|
Prss3
|
protease, serine 3 |
chr1_+_72882806 | 97.34 |
ENSRNOT00000024640
|
Tnni3
|
troponin I3, cardiac type |
chr3_+_79940561 | 94.09 |
ENSRNOT00000016652
|
Mybpc3
|
myosin binding protein C, cardiac |
chr6_-_26385761 | 73.70 |
ENSRNOT00000073228
|
Gckr
|
glucokinase regulator |
chr2_+_190073815 | 66.32 |
ENSRNOT00000015473
|
S100a8
|
S100 calcium binding protein A8 |
chrX_-_13601069 | 61.13 |
ENSRNOT00000004686
|
Otc
|
ornithine carbamoyltransferase |
chr4_+_70689737 | 61.03 |
ENSRNOT00000018852
|
Prss2
|
protease, serine, 2 |
chr1_-_85220237 | 60.22 |
ENSRNOT00000026907
|
Sycn
|
syncollin |
chr8_+_50525091 | 57.94 |
ENSRNOT00000074357
|
Apoa1
|
apolipoprotein A1 |
chr9_-_23493081 | 55.72 |
ENSRNOT00000072144
|
Rhag
|
Rh-associated glycoprotein |
chr20_-_2191640 | 53.26 |
ENSRNOT00000001016
|
Trim10
|
tripartite motif-containing 10 |
chr13_-_53870428 | 50.02 |
ENSRNOT00000000812
|
Nr5a2
|
nuclear receptor subfamily 5, group A, member 2 |
chr6_-_47890033 | 47.14 |
ENSRNOT00000011290
|
Colec11
|
collectin sub-family member 11 |
chr16_+_10267482 | 47.01 |
ENSRNOT00000085255
|
Gdf2
|
growth differentiation factor 2 |
chr5_+_133864798 | 46.57 |
ENSRNOT00000091977
|
Tal1
|
TAL bHLH transcription factor 1, erythroid differentiation factor |
chr11_-_60679555 | 46.54 |
ENSRNOT00000059735
|
Ccdc80
|
coiled-coil domain containing 80 |
chr19_+_27404712 | 44.37 |
ENSRNOT00000023657
|
Mylk3
|
myosin light chain kinase 3 |
chr16_+_6970342 | 44.00 |
ENSRNOT00000061294
ENSRNOT00000048344 |
Itih4
|
inter-alpha-trypsin inhibitor heavy chain family, member 4 |
chr8_-_48672732 | 43.71 |
ENSRNOT00000079275
|
Hmbs
|
hydroxymethylbilane synthase |
chr4_-_70747226 | 42.14 |
ENSRNOT00000044960
|
LOC102554637
|
anionic trypsin-2-like |
chr10_-_90415070 | 42.05 |
ENSRNOT00000055179
|
Itga2b
|
integrin subunit alpha 2b |
chr19_+_25815207 | 41.16 |
ENSRNOT00000003980
|
Lyl1
|
LYL1, basic helix-loop-helix family member |
chr11_-_44049648 | 40.82 |
ENSRNOT00000002257
|
Cpox
|
coproporphyrinogen oxidase |
chr1_+_199720038 | 40.75 |
ENSRNOT00000027297
|
Ahsp
|
alpha hemoglobin stabilizing protein |
chr8_-_33661049 | 40.44 |
ENSRNOT00000068037
|
Fli1
|
Fli-1 proto-oncogene, ETS transcription factor |
chr8_+_22047697 | 39.94 |
ENSRNOT00000067741
|
Icam4
|
intercellular adhesion molecule 4, Landsteiner-Wiener blood group |
chr8_-_22974321 | 39.64 |
ENSRNOT00000017369
|
Epor
|
erythropoietin receptor |
chr11_-_64952687 | 39.35 |
ENSRNOT00000087892
|
Popdc2
|
popeye domain containing 2 |
chr7_-_143538579 | 37.70 |
ENSRNOT00000081518
|
Krt79
|
keratin 79 |
chr7_+_138707426 | 36.54 |
ENSRNOT00000037874
|
Pced1b
|
PC-esterase domain containing 1B |
chr3_-_112985318 | 36.51 |
ENSRNOT00000015556
|
Epb42
|
erythrocyte membrane protein band 4.2 |
chr4_+_57855416 | 35.77 |
ENSRNOT00000029608
|
Cpa2
|
carboxypeptidase A2 |
chr10_+_70417108 | 34.47 |
ENSRNOT00000079325
|
Slfn4
|
schlafen 4 |
chr20_+_34633157 | 33.41 |
ENSRNOT00000000469
|
Pln
|
phospholamban |
chr11_-_35749464 | 32.63 |
ENSRNOT00000078818
ENSRNOT00000078425 |
Erg
|
ERG, ETS transcription factor |
chr20_-_5806097 | 31.27 |
ENSRNOT00000000611
|
Clps
|
colipase |
chr1_+_42121636 | 30.16 |
ENSRNOT00000025616
|
Myct1
|
myc target 1 |
chr10_+_70411738 | 29.96 |
ENSRNOT00000078046
|
Slfn4
|
schlafen 4 |
chr5_+_153197459 | 27.37 |
ENSRNOT00000023187
|
Rhd
|
Rh blood group, D antigen |
chr5_+_164796185 | 27.26 |
ENSRNOT00000010779
|
Nppb
|
natriuretic peptide B |
chr14_-_86146744 | 27.24 |
ENSRNOT00000019335
|
Myl7
|
myosin light chain 7 |
chr4_-_70628470 | 27.06 |
ENSRNOT00000029319
|
Try5
|
trypsin 5 |
chr6_-_7961207 | 26.79 |
ENSRNOT00000007174
|
Abcg5
|
ATP binding cassette subfamily G member 5 |
chr17_-_84247038 | 26.39 |
ENSRNOT00000068553
|
Nebl
|
nebulette |
chr1_+_142883040 | 23.90 |
ENSRNOT00000015898
|
Alpk3
|
alpha-kinase 3 |
chr4_+_51661654 | 23.11 |
ENSRNOT00000087359
ENSRNOT00000072470 |
LOC100909784
|
leiomodin-2-like |
chr11_+_80736576 | 22.88 |
ENSRNOT00000047678
|
Masp1
|
mannan-binding lectin serine peptidase 1 |
chr1_-_222272285 | 22.81 |
ENSRNOT00000028737
|
Fermt3
|
fermitin family member 3 |
chrX_+_53053609 | 21.55 |
ENSRNOT00000058357
|
Dmd
|
dystrophin |
chr4_-_7342410 | 20.81 |
ENSRNOT00000013058
|
Nos3
|
nitric oxide synthase 3 |
chr9_+_52023295 | 20.39 |
ENSRNOT00000004956
|
Col3a1
|
collagen type III alpha 1 chain |
chr15_-_52399074 | 20.13 |
ENSRNOT00000018440
|
Xpo7
|
exportin 7 |
chr19_+_55094585 | 19.87 |
ENSRNOT00000068452
|
Zfpm1
|
zinc finger protein, multitype 1 |
chr5_+_151776004 | 19.80 |
ENSRNOT00000009683
|
Nr0b2
|
nuclear receptor subfamily 0, group B, member 2 |
chr16_+_2634603 | 18.39 |
ENSRNOT00000019113
|
Hesx1
|
HESX homeobox 1 |
chr9_-_49950093 | 18.19 |
ENSRNOT00000023014
|
Fhl2
|
four and a half LIM domains 2 |
chr13_-_61591139 | 17.88 |
ENSRNOT00000005324
|
Rgs18
|
regulator of G-protein signaling 18 |
chr3_+_55910177 | 17.76 |
ENSRNOT00000009969
|
Klhl41
|
kelch-like family member 41 |
chr17_+_8489266 | 17.71 |
ENSRNOT00000016252
|
Lect2
|
leukocyte cell-derived chemotaxin 2 |
chr1_-_275906686 | 17.60 |
ENSRNOT00000092170
|
Gpam
|
glycerol-3-phosphate acyltransferase, mitochondrial |
chr12_+_40244081 | 16.70 |
ENSRNOT00000030583
|
Sh2b3
|
SH2B adaptor protein 3 |
chr4_-_170932618 | 16.55 |
ENSRNOT00000007779
|
Arhgdib
|
Rho GDP dissociation inhibitor beta |
chr7_+_59326518 | 16.37 |
ENSRNOT00000085231
|
Ptprb
|
protein tyrosine phosphatase, receptor type, B |
chr10_-_104628676 | 16.08 |
ENSRNOT00000010466
|
Unc13d
|
unc-13 homolog D |
chr5_-_76632462 | 15.76 |
ENSRNOT00000085109
|
Susd1
|
sushi domain containing 1 |
chr20_-_5076539 | 15.51 |
ENSRNOT00000076253
ENSRNOT00000037613 |
Ly6g6f
|
lymphocyte antigen 6 complex, locus G6F |
chr5_+_25168295 | 15.23 |
ENSRNOT00000020245
|
Fsbp
|
fibrinogen silencer binding protein |
chr17_+_9639330 | 15.17 |
ENSRNOT00000018232
|
Dok3
|
docking protein 3 |
chr14_-_21252538 | 14.43 |
ENSRNOT00000005003
|
Ambn
|
ameloblastin |
chr20_+_27954433 | 14.09 |
ENSRNOT00000064288
|
Lims1
|
LIM zinc finger domain containing 1 |
chr3_-_148722710 | 14.05 |
ENSRNOT00000090919
ENSRNOT00000068592 |
Plagl2
|
PLAG1 like zinc finger 2 |
chr10_+_107455845 | 13.46 |
ENSRNOT00000004373
|
C1qtnf1
|
C1q and tumor necrosis factor related protein 1 |
chr1_-_258877045 | 13.43 |
ENSRNOT00000071633
|
Cyp2c13
|
cytochrome P450, family 2, subfamily c, polypeptide 13 |
chr2_-_198002625 | 12.83 |
ENSRNOT00000091888
|
BC028528
|
cDNA sequence BC028528 |
chr4_+_158088505 | 12.72 |
ENSRNOT00000026643
|
Vwf
|
von Willebrand factor |
chr6_-_127653124 | 12.15 |
ENSRNOT00000047324
|
Serpina11
|
serpin family A member 11 |
chr5_-_79691258 | 12.03 |
ENSRNOT00000072920
|
Tnfsf8
|
tumor necrosis factor superfamily member 8 |
chr6_+_7961413 | 12.02 |
ENSRNOT00000007638
ENSRNOT00000061871 |
Abcg8
|
ATP binding cassette subfamily G member 8 |
chr7_+_12144162 | 11.31 |
ENSRNOT00000077122
|
Tcf3
|
transcription factor 3 |
chr10_+_108132105 | 11.29 |
ENSRNOT00000072534
|
Cbx2
|
chromobox 2 |
chr2_+_227080924 | 10.99 |
ENSRNOT00000029871
|
Fabp2
|
fatty acid binding protein 2 |
chr19_-_37916813 | 10.77 |
ENSRNOT00000026585
|
Lcat
|
lecithin cholesterol acyltransferase |
chr7_+_117967818 | 10.59 |
ENSRNOT00000073724
|
LOC100360117
|
ribosomal protein L8-like |
chr16_-_73827488 | 10.56 |
ENSRNOT00000064070
|
Ank1
|
ankyrin 1 |
chr15_+_34234755 | 10.35 |
ENSRNOT00000059987
|
Dcaf11
|
DDB1 and CUL4 associated factor 11 |
chr16_+_31734944 | 9.80 |
ENSRNOT00000059673
|
Palld
|
palladin, cytoskeletal associated protein |
chr5_+_154522119 | 9.57 |
ENSRNOT00000072618
|
E2f2
|
E2F transcription factor 2 |
chr3_+_93909156 | 8.99 |
ENSRNOT00000090365
|
Lmo2
|
LIM domain only 2 |
chr3_+_4034921 | 8.48 |
ENSRNOT00000026318
|
Egfl7
|
EGF-like-domain, multiple 7 |
chr7_-_70467915 | 8.08 |
ENSRNOT00000088995
|
Slc26a10
|
solute carrier family 26, member 10 |
chr17_-_27112820 | 7.98 |
ENSRNOT00000018359
|
Bmp6
|
bone morphogenetic protein 6 |
chr3_+_59153280 | 7.71 |
ENSRNOT00000002066
|
Cdca7
|
cell division cycle associated 7 |
chr10_+_103874383 | 7.41 |
ENSRNOT00000038935
|
Otop2
|
otopetrin 2 |
chr2_-_96668222 | 7.20 |
ENSRNOT00000016567
|
Pkia
|
cAMP-dependent protein kinase inhibitor alpha |
chr3_+_56766475 | 7.13 |
ENSRNOT00000078819
|
Sp5
|
Sp5 transcription factor |
chr6_+_137164535 | 6.70 |
ENSRNOT00000018225
|
Inf2
|
inverted formin, FH2 and WH2 domain containing |
chr20_+_31265483 | 6.60 |
ENSRNOT00000079584
ENSRNOT00000000674 |
Ppa1
|
pyrophosphatase (inorganic) 1 |
chr2_-_60657712 | 6.37 |
ENSRNOT00000040348
|
Rai14
|
retinoic acid induced 14 |
chr4_-_165541314 | 6.30 |
ENSRNOT00000013833
|
Styk1
|
serine/threonine/tyrosine kinase 1 |
chr19_+_37600148 | 6.27 |
ENSRNOT00000023853
|
Ctcf
|
CCCTC-binding factor |
chr1_-_221370322 | 6.24 |
ENSRNOT00000028431
|
Capn1
|
calpain 1 |
chr3_+_72447969 | 5.75 |
ENSRNOT00000012022
|
Ssrp1
|
structure specific recognition protein 1 |
chr5_-_147584038 | 5.65 |
ENSRNOT00000010983
|
Zbtb8a
|
zinc finger and BTB domain containing 8a |
chr20_-_27657983 | 5.61 |
ENSRNOT00000057313
|
Fam26e
|
family with sequence similarity 26, member E |
chr2_+_208373154 | 5.53 |
ENSRNOT00000082943
ENSRNOT00000050538 |
LOC100911796
|
adenosine receptor A3-like |
chrX_+_83678339 | 5.46 |
ENSRNOT00000005997
|
Apool
|
apolipoprotein O-like |
chr3_-_72447801 | 5.10 |
ENSRNOT00000088815
|
P2rx3
|
purinergic receptor P2X 3 |
chr2_-_105047984 | 4.98 |
ENSRNOT00000014970
|
Cpa3
|
carboxypeptidase A3 |
chr10_+_83154423 | 4.85 |
ENSRNOT00000005939
|
Fam117a
|
family with sequence similarity 117, member A |
chr7_-_143392777 | 4.73 |
ENSRNOT00000086504
ENSRNOT00000038105 |
Krt72
|
keratin 72 |
chr4_+_102290338 | 4.68 |
ENSRNOT00000011067
|
AABR07060992.1
|
|
chr10_+_57260680 | 4.66 |
ENSRNOT00000035445
|
Gp1ba
|
glycoprotein Ib platelet alpha subunit |
chr14_-_45165207 | 4.44 |
ENSRNOT00000002960
|
Klf3
|
Kruppel like factor 3 |
chr20_+_46428124 | 4.42 |
ENSRNOT00000000327
|
Foxo3
|
forkhead box O3 |
chr5_+_33097654 | 4.26 |
ENSRNOT00000008087
|
Cngb3
|
cyclic nucleotide gated channel beta 3 |
chr17_+_76008807 | 3.73 |
ENSRNOT00000070895
|
Echdc3
|
enoyl CoA hydratase domain containing 3 |
chr5_+_57239086 | 3.33 |
ENSRNOT00000060714
|
Spink4
|
serine peptidase inhibitor, Kazal type 4 |
chr3_-_74815509 | 3.30 |
ENSRNOT00000045173
|
Olr499
|
olfactory receptor 499 |
chr11_-_78327282 | 2.59 |
ENSRNOT00000002636
|
Tp63
|
tumor protein p63 |
chr14_-_18862407 | 2.53 |
ENSRNOT00000003823
|
Cxcl6
|
C-X-C motif chemokine ligand 6 |
chr1_+_88451958 | 2.34 |
ENSRNOT00000074301
|
LOC102549115
|
zinc finger protein 260-like |
chr2_-_189602143 | 2.27 |
ENSRNOT00000032062
|
Creb3l4
|
cAMP responsive element binding protein 3-like 4 |
chr1_+_243375981 | 2.20 |
ENSRNOT00000080689
|
Kank1
|
KN motif and ankyrin repeat domains 1 |
chr16_+_54291251 | 2.13 |
ENSRNOT00000079006
|
Mtus1
|
microtubule associated tumor suppressor 1 |
chr11_-_782954 | 1.95 |
ENSRNOT00000040065
|
Epha3
|
Eph receptor A3 |
chr1_-_242373764 | 1.77 |
ENSRNOT00000076544
|
Fam122a
|
family with sequence similarity 122A |
chr17_-_44948432 | 1.77 |
ENSRNOT00000092195
|
LOC103690297
|
putative olfactory receptor 2W6 |
chr1_+_175445088 | 1.71 |
ENSRNOT00000036718
|
Adm
|
adrenomedullin |
chr1_-_126211439 | 1.66 |
ENSRNOT00000014988
|
Tjp1
|
tight junction protein 1 |
chr10_-_102227554 | 1.56 |
ENSRNOT00000078035
|
AC096468.1
|
|
chr7_+_71023976 | 1.29 |
ENSRNOT00000005679
|
Tac3
|
tachykinin 3 |
chr10_+_83840303 | 1.28 |
ENSRNOT00000008481
|
Gip
|
gastric inhibitory polypeptide |
chr12_+_22274828 | 1.22 |
ENSRNOT00000001914
|
Epo
|
erythropoietin |
chr3_+_159936856 | 1.14 |
ENSRNOT00000078703
|
Hnf4a
|
hepatocyte nuclear factor 4, alpha |
chr7_-_5106708 | 0.98 |
ENSRNOT00000046001
|
Olr892
|
olfactory receptor 892 |
chr10_-_42928461 | 0.86 |
ENSRNOT00000058619
|
Fam114a2
|
family with sequence similarity 114, member A2 |
chr3_+_76842898 | 0.78 |
ENSRNOT00000085537
|
Olr636
|
olfactory receptor 636 |
chr1_+_169636914 | 0.73 |
ENSRNOT00000074466
|
Olr158
|
olfactory receptor 158 |
chr1_+_169951913 | 0.72 |
ENSRNOT00000040861
|
Olr189
|
olfactory receptor 189 |
chr4_-_155690869 | 0.67 |
ENSRNOT00000012216
|
C3ar1
|
complement C3a receptor 1 |
chr7_+_5593735 | 0.65 |
ENSRNOT00000042179
|
Olr917
|
olfactory receptor 917 |
chr10_+_61403130 | 0.62 |
ENSRNOT00000092490
ENSRNOT00000077649 |
Ccdc92b
|
coiled-coil domain containing 92B |
chr10_-_39054142 | 0.59 |
ENSRNOT00000063772
|
Rad50
|
RAD50 double strand break repair protein |
chr6_-_7421456 | 0.53 |
ENSRNOT00000006725
|
Zfp36l2
|
zinc finger protein 36, C3H type-like 2 |
chr17_-_78561613 | 0.41 |
ENSRNOT00000020220
|
Fam107b
|
family with sequence similarity 107, member B |
chr15_+_33069382 | 0.33 |
ENSRNOT00000060193
|
Mrpl52
|
mitochondrial ribosomal protein L52 |
chr14_+_85230648 | 0.27 |
ENSRNOT00000089866
|
Ap1b1
|
adaptor-related protein complex 1, beta 1 subunit |
chr4_+_10748745 | 0.25 |
ENSRNOT00000046142
|
Rsbn1l
|
round spermatid basic protein 1-like |
chr10_-_36502313 | 0.22 |
ENSRNOT00000041273
|
LOC679794
|
similar to Cytochrome c, somatic |
chr2_-_123851854 | 0.04 |
ENSRNOT00000023327
|
Il2
|
interleukin 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
40.5 | 121.4 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
35.8 | 179.0 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
19.3 | 57.9 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
16.6 | 66.4 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
14.8 | 133.4 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
14.7 | 73.7 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) negative regulation of glucokinase activity(GO:0033132) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) negative regulation of hexokinase activity(GO:1903300) |
13.1 | 39.4 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
12.5 | 50.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
12.2 | 61.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
9.9 | 39.6 | GO:1904373 | response to kainic acid(GO:1904373) |
9.7 | 38.8 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
9.4 | 94.1 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
8.8 | 26.4 | GO:0071691 | cardiac muscle thin filament assembly(GO:0071691) |
8.2 | 130.7 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
8.0 | 55.7 | GO:0015670 | carbon dioxide transport(GO:0015670) |
7.7 | 84.5 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
7.2 | 21.5 | GO:0021627 | muscle attachment(GO:0016203) olfactory nerve morphogenesis(GO:0021627) olfactory nerve structural organization(GO:0021629) |
7.1 | 120.7 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
6.8 | 20.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
5.5 | 16.6 | GO:0071461 | cellular response to redox state(GO:0071461) |
5.4 | 32.6 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) positive regulation of blood vessel remodeling(GO:2000504) |
5.4 | 16.1 | GO:0002432 | granuloma formation(GO:0002432) |
5.4 | 21.4 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
5.2 | 20.8 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
4.7 | 66.3 | GO:0017014 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
4.1 | 41.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
3.9 | 27.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
3.3 | 23.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
3.1 | 18.4 | GO:0030916 | otic vesicle formation(GO:0030916) |
2.7 | 61.0 | GO:0030574 | collagen catabolic process(GO:0030574) |
2.4 | 42.8 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
2.3 | 53.9 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
2.2 | 35.0 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
2.1 | 40.4 | GO:0035855 | megakaryocyte development(GO:0035855) |
2.1 | 27.4 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
2.1 | 22.8 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
2.0 | 17.6 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
1.9 | 22.9 | GO:2000258 | complement activation, lectin pathway(GO:0001867) negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
1.8 | 10.8 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
1.8 | 14.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.6 | 9.6 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.5 | 44.0 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
1.5 | 18.2 | GO:0060347 | heart trabecula formation(GO:0060347) |
1.4 | 11.3 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
1.4 | 12.7 | GO:0070417 | cellular response to cold(GO:0070417) |
1.2 | 17.8 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
1.2 | 14.0 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
1.0 | 25.7 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.9 | 64.4 | GO:0048286 | lung alveolus development(GO:0048286) |
0.9 | 46.7 | GO:0070527 | platelet aggregation(GO:0070527) |
0.9 | 12.0 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.8 | 2.5 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.8 | 6.3 | GO:0010216 | maintenance of DNA methylation(GO:0010216) nucleosome positioning(GO:0016584) |
0.8 | 79.8 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.7 | 4.4 | GO:0071386 | cellular response to corticosterone stimulus(GO:0071386) |
0.7 | 5.1 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.7 | 10.6 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.7 | 90.8 | GO:0031638 | zymogen activation(GO:0031638) |
0.7 | 7.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.7 | 2.0 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
0.6 | 6.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.6 | 9.8 | GO:0003334 | keratinocyte development(GO:0003334) |
0.6 | 5.0 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.5 | 2.2 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.5 | 31.3 | GO:0032094 | response to food(GO:0032094) |
0.5 | 5.5 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.5 | 13.4 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.5 | 59.3 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
0.4 | 1.7 | GO:0060529 | ectoderm and mesoderm interaction(GO:0007499) epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) female genitalia morphogenesis(GO:0048807) squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) |
0.4 | 34.9 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.4 | 46.5 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.3 | 5.5 | GO:0042407 | cristae formation(GO:0042407) |
0.3 | 8.5 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.3 | 1.1 | GO:0042977 | regulation of activation of JAK2 kinase activity(GO:0010534) activation of JAK2 kinase activity(GO:0042977) negative regulation of activation of JAK2 kinase activity(GO:1902569) |
0.3 | 1.7 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.3 | 17.1 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.3 | 1.3 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.2 | 0.7 | GO:0002462 | tolerance induction to nonself antigen(GO:0002462) |
0.2 | 1.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 1.7 | GO:0071000 | response to magnetism(GO:0071000) |
0.2 | 13.3 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.2 | 6.3 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.2 | 17.9 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.2 | 11.0 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.2 | 14.4 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.2 | 19.8 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.2 | 10.6 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.2 | 111.4 | GO:0051603 | proteolysis involved in cellular protein catabolic process(GO:0051603) |
0.2 | 16.4 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.5 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.1 | 2.1 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 7.1 | GO:0060349 | bone morphogenesis(GO:0060349) |
0.1 | 61.7 | GO:0006508 | proteolysis(GO:0006508) |
0.1 | 2.3 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.1 | 1.1 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.0 | 0.0 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
24.3 | 97.3 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
15.7 | 94.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
12.9 | 38.8 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
11.6 | 57.9 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
11.1 | 33.4 | GO:0090534 | calcium ion-transporting ATPase complex(GO:0090534) |
2.8 | 16.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
2.3 | 46.5 | GO:0005614 | interstitial matrix(GO:0005614) |
1.7 | 20.4 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
1.6 | 46.5 | GO:0031430 | M band(GO:0031430) |
1.6 | 27.2 | GO:0031672 | A band(GO:0031672) |
1.2 | 169.1 | GO:0030018 | Z disc(GO:0030018) |
1.2 | 42.1 | GO:0008305 | integrin complex(GO:0008305) |
1.1 | 11.0 | GO:0045179 | apical cortex(GO:0045179) |
0.8 | 5.5 | GO:0061617 | MICOS complex(GO:0061617) |
0.8 | 11.3 | GO:0035102 | PRC1 complex(GO:0035102) |
0.7 | 25.9 | GO:0002102 | podosome(GO:0002102) |
0.7 | 42.4 | GO:0045095 | keratin filament(GO:0045095) |
0.7 | 60.2 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.7 | 1006.0 | GO:0005615 | extracellular space(GO:0005615) |
0.5 | 36.5 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.5 | 61.3 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.4 | 51.0 | GO:0042383 | sarcolemma(GO:0042383) |
0.4 | 10.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.4 | 4.7 | GO:0031362 | intrinsic component of external side of plasma membrane(GO:0031233) anchored component of external side of plasma membrane(GO:0031362) |
0.4 | 19.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 26.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 5.1 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.3 | 50.6 | GO:0000793 | condensed chromosome(GO:0000793) |
0.2 | 39.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.2 | 61.5 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.2 | 9.9 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 1.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 30.9 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 35.1 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.1 | 21.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 16.4 | GO:0043235 | receptor complex(GO:0043235) |
0.1 | 4.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 6.3 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 6.4 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 56.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 25.2 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) |
0.0 | 21.7 | GO:0016604 | nuclear body(GO:0016604) |
0.0 | 1.1 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 2.0 | GO:0005769 | early endosome(GO:0005769) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
24.3 | 97.3 | GO:0030172 | troponin C binding(GO:0030172) |
21.0 | 146.9 | GO:0031433 | telethonin binding(GO:0031433) |
19.3 | 57.9 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
14.6 | 43.7 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
13.5 | 121.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
11.1 | 44.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
11.1 | 66.3 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
10.5 | 73.7 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
8.6 | 94.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
7.0 | 42.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
7.0 | 55.7 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
6.7 | 133.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
6.5 | 176.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
5.8 | 40.8 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
5.8 | 40.8 | GO:0030492 | hemoglobin binding(GO:0030492) |
5.6 | 77.8 | GO:0042301 | phosphate ion binding(GO:0042301) |
5.2 | 20.8 | GO:0034618 | arginine binding(GO:0034618) |
4.8 | 33.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
3.7 | 36.5 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
3.6 | 14.4 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
3.3 | 49.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
2.9 | 17.6 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
2.8 | 11.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
2.5 | 20.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
2.3 | 120.7 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
2.2 | 10.8 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
2.1 | 10.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.8 | 11.0 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
1.6 | 44.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
1.6 | 46.5 | GO:0001968 | fibronectin binding(GO:0001968) |
1.5 | 134.9 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
1.5 | 20.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.5 | 319.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
1.3 | 6.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.2 | 7.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
1.1 | 16.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
1.1 | 27.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
1.1 | 21.5 | GO:0017166 | vinculin binding(GO:0017166) |
1.0 | 52.2 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
1.0 | 39.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.9 | 19.8 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.7 | 75.5 | GO:0005178 | integrin binding(GO:0005178) |
0.6 | 5.1 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.5 | 4.3 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.4 | 13.4 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.4 | 1.2 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.4 | 8.1 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.4 | 8.5 | GO:0005112 | Notch binding(GO:0005112) |
0.4 | 15.2 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.3 | 44.5 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.3 | 29.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.3 | 2.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 12.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.3 | 1.7 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 6.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.3 | 9.0 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 2.0 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.2 | 2.5 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 11.3 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 16.4 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 6.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 71.7 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.1 | 0.6 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 9.6 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 17.9 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 41.7 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.7 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 6.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.5 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 10.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 3.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 7.8 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 18.3 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 0.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 66.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.8 | 57.6 | PID EPO PATHWAY | EPO signaling pathway |
1.7 | 44.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
1.7 | 121.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
1.5 | 47.0 | PID ALK1 PATHWAY | ALK1 signaling events |
1.5 | 42.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
1.4 | 338.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
1.2 | 19.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
1.2 | 20.8 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
1.1 | 59.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.7 | 24.0 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.7 | 12.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.7 | 17.0 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.6 | 9.6 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.6 | 55.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.5 | 11.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.5 | 37.6 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.4 | 130.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.4 | 59.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.4 | 14.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.3 | 16.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 6.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.2 | 8.2 | PID ENDOTHELIN PATHWAY | Endothelins |
0.2 | 4.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 2.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 7.1 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 4.4 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 16.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.7 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 1.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.6 | PID BARD1 PATHWAY | BARD1 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.6 | 121.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
6.8 | 61.0 | REACTOME DEFENSINS | Genes involved in Defensins |
5.4 | 272.2 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
5.0 | 84.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
3.0 | 54.8 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
2.9 | 112.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
2.5 | 73.7 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
2.1 | 22.9 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
1.7 | 20.8 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
1.4 | 51.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.9 | 17.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.8 | 14.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.8 | 39.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.8 | 16.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.6 | 9.6 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.5 | 4.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 11.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 19.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 6.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 5.7 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.2 | 4.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 37.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 19.9 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 1.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 12.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 2.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 1.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 5.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 3.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.6 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |